209 related articles for article (PubMed ID: 19852957)
21. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye.
Hsueh PY; Ju Y; Vega A; Edman MC; MacKay JA; Hamm-Alvarez SF
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326657
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of early-phase Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes.
Peck AB; Saylor BT; Nguyen L; Sharma A; She JX; Nguyen CQ; McIndoe RA
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5647-55. PubMed ID: 21666236
[TBL] [Abstract][Full Text] [Related]
24. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
[TBL] [Abstract][Full Text] [Related]
25. Altered distribution of aquaporin 5 and its C-terminal binding protein in the lacrimal glands of a mouse model for Sjögren's syndrome.
Ohashi Y; Tsuzaka K; Takeuchi T; Sasaki Y; Tsubota K
Curr Eye Res; 2008 Aug; 33(8):621-9. PubMed ID: 18696337
[TBL] [Abstract][Full Text] [Related]
26. Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction.
You IC; Bian F; Volpe EA; de Paiva CS; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2224-33. PubMed ID: 25758816
[TBL] [Abstract][Full Text] [Related]
27. Changes of aquaporins in the lacrimal glands of a rabbit model of Sjögren's syndrome.
Ding C; Nandoskar P; Lu M; Thomas P; Trousdale MD; Wang Y
Curr Eye Res; 2011 Jun; 36(6):571-8. PubMed ID: 21524183
[TBL] [Abstract][Full Text] [Related]
28. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
29. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
[TBL] [Abstract][Full Text] [Related]
30. Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.
Ju Y; Edman MC; Guo H; Janga SR; Peddi S; Louie SG; Junge JA; MacKay JA; Hamm-Alvarez SF
Biomacromolecules; 2021 Mar; 22(3):1102-1114. PubMed ID: 33356170
[TBL] [Abstract][Full Text] [Related]
31. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
33. Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome.
Guo H; Ju Y; Choi M; Edman MC; Louie SG; Hamm-Alvarez SF; MacKay JA
Biomaterials; 2022 Apr; 283():121441. PubMed ID: 35306230
[TBL] [Abstract][Full Text] [Related]
34. Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.
Killedar SJ; Eckenrode SE; McIndoe RA; She JX; Nguyen CQ; Peck AB; Cha S
Lab Invest; 2006 Dec; 86(12):1243-60. PubMed ID: 17075579
[TBL] [Abstract][Full Text] [Related]
35. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
36. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
37. Integrated DNA Methylation and Transcriptomics Analyses of Lacrimal Glands Identify the Potential Genes Implicated in the Development of Sjögren's Syndrome-Related Dry Eye.
Sun M; Wei Y; Zhang C; Nian H; Du B; Wei R
J Inflamm Res; 2023; 16():5697-5714. PubMed ID: 38050559
[TBL] [Abstract][Full Text] [Related]
38. Normal and Sjogren's syndrome models of the murine lacrimal gland studied at single-cell resolution.
Rattner A; Heng JS; Winer BL; Goff LA; Nathans J
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2311983120. PubMed ID: 37812717
[TBL] [Abstract][Full Text] [Related]
39. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
40. The protein kinase C system in focal adenitis of the lacrimal gland in the non-obese diabetic mouse model for Sjögren's syndrome.
Tensing EK; Törnwall J; Hukkanen M; Nordström DC; Konttinen YT
Acta Ophthalmol Scand; 2004 Oct; 82(5):569-73. PubMed ID: 15453855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]